New Aspirin Study Contradicts Previous Research

Yahoo Contributor Network

A new study on the benefits of aspirin published on Monday contradicts previous research on the drug. Researchers focused on the overall cancer prevention abilities of aspirin and found that low doses were sufficient in reducing the chance of getting the disease. However, the study conflicts with previous research that revealed a daily dose of aspirin may not provide any real benefits while increasing the risk of internal bleeding.

The study published on Monday in the journal of Nature Reviews Clinical Oncology reveals that taking 75 to 100 mg of aspirin a day could significantly reduce the chance of getting cancer. The researchers claim that aspirin was responsible for a reduction of 20 percent in the likelihood of patients having cancer. Additionally, doses above 100 mg did not provide any added benefits.

For several years, studies have wavered between exalting and disapproving of aspirin. More than a dozen different health benefits have been attributed to the use of this drug. Moving beyond its popularity as a fever reducer and pain reliever, aspirin has become a popular preventive tool in the fight against cardiovascular diseases. However, there are risks involved with the use of this drug.

Bleeding is the most commonly cited side effect of aspirin, but it is not the only problem. Reye's Syndrome has been linked in some studies to the use of aspirin. This disease often causes fatal damage to organs. Aspirin has also been linked to ulcers, tinnitus and other issues.

The role of aspirin therapy in preventive medicine has recently been questioned and conflicts with the research published on Monday. A study from the University Medical Center (UMC) Utrecht analyzed the impact of using aspirin in a large sample. In addition to finding that the drug was not effective for women over the age of 65 without any cardiovascular problems, the researchers focused on the general lack of benefits for healthy adults.

The new study from the journal Nature Reviews Clinical Oncology that cites a positive link between aspirin and a lower incidence of cancer needs to be processed carefully. Although aspirin can be a useful tool for adults suffering from or at risk of cardiovascular problems, healthy people may need to carefully weigh the risks of taking a preventive drug.

View Comments (7)